Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Bioxcel therapeutics, inc.    crawled date : 2021 - 02 - 25    save search
BioXcel Therapeutics Announces Initiation of Phase 2 PLACIDITY Trial of BXCL501 for the Treatment of Delirium Related AgitationTopline results are expected in Q1 2022
Published: 2021-02-25 (Crawled : 19:00) - biospace.com/
BTAI | News | $2.96 -0.34% 620K twitter stocktwits trandingview |
Health Technology
 | | O: 0.84% H: 5.05% C: -4.02%
treatment phase 2 results trial
BioXcel Therapeutics Announces Initiation of Phase 2 PLACIDITY Trial of BXCL501 for the Treatment of Delirium Related Agitation
Published: 2021-02-25 (Crawled : 12:03) - globenewswire.com
BTAI | News | $2.96 -0.34% 620K twitter stocktwits trandingview |
Health Technology
 | | O: 0.84% H: 5.05% C: -4.02%
treatment phase 2 trial
Gainers vs Losers
66% 34%

Top 10 Gainers
CZOO | $11.44 129.26% 4.6M twitter stocktwits trandingview |

AMST | $3.4 70.0% 51M twitter stocktwits trandingview |
Technology Services
BOF | $1.78 52.14% 15M twitter stocktwits trandingview |

CSSE 4 | $0.23 51.02% 46M twitter stocktwits trandingview |
Consumer Services
TROO | $1.57 44.04% 2.8M twitter stocktwits trandingview |
Manufacturing
RILY | $30.87 42.13% 7.8M twitter stocktwits trandingview |
Finance
LICN | $0.76 35.71% 6.2M twitter stocktwits trandingview |

MULN | News | $3.53 29.3% 4.8M twitter stocktwits trandingview |
Information
RBBN 4 | $3.26 26.85% 1.2M twitter stocktwits trandingview |
Electronic Technology
RCAT | $1.52 26.67% 1.3M twitter stocktwits trandingview |
Information
Your saved searches
Save your searches and get alerts when important news are released.